Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Visceral Sensitivity in IBD and IBS: Role of Inflammation, Immune Activity and Genetic Factors

NCT02421705 is registered in ClinicalTrials.gov with KU Leuven as lead sponsor.

NCT NCT02421705
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02421705 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Visceral Sensitivity in IBD and IBS: Role of Inflammation, Immune Activity and Genetic Factors
Lead sponsor
KU Leuven
Phase
Not applicable
Overall status
Recruiting
Start date
February 28, 2010
Completion date
January 31, 2099
Enrollment
Not reported
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

crohn's disease, active, crohn's disease, remission (6a: with ibs symptoms, 6b: without ibs symptoms), healthy controls, ibs, ulcerative colitis, active, ulcerative colitis, remission (3a: with ibs symptoms, 3b: without ibs symptoms)